Australia clears sale of new IMRIS devices
March 25, 2010 by stephenkilmer · Leave a Comment
IMRIS (TSX:IM) has received clearance from Australia’s Therapeutic Goods Administration for the marketing of the company’s newest products, IMRISNV and IMRIScardio. IMRISNV and IMRIScardio are the first systems in the world to allow both MRI and X-ray angiography in a single suite without the need to transport the patient between modalities. The devices have been [...]
Listen to BioTuesdays 
